🇺🇸 FDA
Patent

US 10420812

Drug combinations and uses in treating a coughing condition

granted A61KA61K31/375A61K31/522

Quick answer

US patent 10420812 (Drug combinations and uses in treating a coughing condition) held by Infirst Healthcare Limited expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/375, A61K31/522, A61K36/534, A61K45/06